Hahn & Co., a Korean private equity investment company, has completed the acquisition of Cynosure, a U.S. medical aesthetics company specializing in laser and light-based treatments, and is now taking steps to integrate Cynosure with Lutronic, a developer of advanced medical and aesthetic lasers and
Yuyu Pharma said its urinary disorder treatment Yuhylyx Soft Capsule (dutasteride) has won approval from the food and drug administration of the Philippines and Myanmar and has completed product registration.These are expected to boost the company's exports to the Southeast Asian pharmaceutical mark
Pfizer Korea and Hanlim MS are strengthening their partnership to co-market immunology disease treatments.Pfizer Korea said Tuesday that the company has signed an agreement with Hanlim MS to co-market Enbrel (etanercept), the first anti-tumor necrosis factor (TNF)-α inhibitor approved for treating r
JW Pharmaceutical said Monday that interim results from a long-term study of Hemlibra (emicizumab) in children with severe non-antibody hemophilia A confirmed that the drug improved joint health in patients.Hemlibra is a breakthrough medicine that mimics factor 8, a blood clotting factor deficient i
Lunit, a medical artificial intelligence (AI) company, said Monday it would present seven research findings using its AI biomarker platform, Lunit Scope, at the American Association for Cancer Research (AACR) 2024 in San Diego, Calif., from April 5-10.In a poster presentation, Lunit will demonstrate
MSD Korea said its new 15-valent pneumococcal protein conjugate vaccine, Vaxneuvance, will be available for free at hospitals and clinics nationwide starting Monday as part of the National Immunization Program (NIP) for children.Vaxneuvance is indicated for preventing invasive disease and pneumonia
CHA Biotech and Centenaire Biosciences have agreed to expand their collaboration on natural killer (NK) cell-antibody combination research. To this end, CHA Biotech transferred its NK cell therapeutic candidate to Centenaire Biosciences.The two companies will combine CHA Biotech's NK cells with Cent
Korean researchers have analyzed the effects of nanolastics on the metabolism of offspring.The Korea Research Institute of Bioscience and Biotechnology (KRIBB) said its research team, led by Dr. Lee Da-yong of the Center for Rare and Difficult Diseases, has found that nanoplastics are transferred to
Celltrion, a Korean biopharmaceutical giant, said it has launched a 20-mg dosage formulation of its biosimilar Yuflyma (adalimumab) to treat autoimmune diseases in pediatric patients in the U.S.Yuflyma 20mg is the same high-concentration (100mg/mL) formulation as the 40mg and 80 mg, which were launc
Coreline Soft, a medical AI company, has begun to generate results by strengthening its solution supply contracts and partnerships with leading European hospitals.Coreline Soft said Thursday that it has signed a contract to supply its flagship product, AVIEW LCS Plus, a simultaneous diagnosis soluti
Takeda Pharmaceuticals Korea said on Thursday that Livtencity (ingredient: maribavir), a tablet for cytomegalovirus (CMV) infection and disease after transplantation, will be covered by Korean national health insurance starting April 1.Livtencity is an antiviral pill developed to treat CMV infection
Bridge Biotherapeutics said Wednesday it has signed collaborative research agreements with the University of Colorado and Emory University to explore the potential for expanding the indications of BBT-877, an autotaxin inhibitor, as an immuno-oncology agent.The company added that the joint researche
Myongji Hospital and Rokit Healthcare, a company specializing in organ regeneration, have agreed to join forces to research and develop diabetic foot treatment technology using 3D bioprinting.Myongji Hospital President Kim Jin-goo and Rokit Healthcare Chairman and CEO You Seok-hwan signed the agreem
Kakao Healthcare said Tuesday that it has signed a business agreement with healthcare startup Brave Company to develop and spread exercise content for proper blood sugar management.Through the agreement, Kakao Healthcare's medical experts and Brave Company's exercise experts will jointly plan and de
Dong-A ST said it signed a joint sales agreement with Yuyu Pharma on Monday for the peripheral circulation improvement drug Tanamine Tablet at the latter’s headquarters in Shindang-dong, Jung-gu, Seoul.The two companies' senior managers, including Dong-A ST CEO Kim Min-young and Yuyu Pharma CEO Yu W
In vitro diagnostics company Precision Biosensor has begun commercializing personalized diagnostic equipment, Egoo Health System, by collaborating with its Danish partner Qlife.Qlife, which was listed on the Nasdaq First North Growth Market, an alternative stock exchange for small- and mid-sized gro
Celltrion said Monday it has received a recommendation from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) to grant the marketing authorization for the full-label application of CT-P39, a biosimilar to Xolair (omalizumab).CT-P39's original drug, Xolair, i
Medical AI company AITRICS said Thursday that it has raised Series B funding totaling 27.1 billion won ($20.4 million) from nine Korean and foreign venture capital firms.For the Series B round, existing investors like Premier Partners, BNH Investment, and BSK Investment made follow-on investments, w
SK bioscience has begun exporting its cell-cultured influenza vaccine, SKY Cellflu, signaling the company's expansion into the Southeast Asian market and its entry into the southern hemisphere.SK bioscience said Thursday that it has shipped about 440,000 doses of SKY Cellflu to its Thai partner Biog
Boston Scientific said Monday that it would expand technical support for the Lumenis Pulse 120H Holmium Laser System based on the MOSES technology and further strengthen its leadership in stone treatment in Korea.According to Boston Scientific, the company has recently enhanced the expertise of its